Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Fries

Showing results (161-170 of 247) with videos related to

Pageof 25
Sort By:
Arthritis and Rheumatism|November 1, 1990
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisJ F Fries, G Singh, L Lenert, et al.
The Journal of Rheumatology|July 1, 1989
The natural history of ankylosing spondylitis: is the disease really changing?J F Fries, G Singh, D A Bloch, et al.
Pharmacology & Therapeutics|April 1, 1994
Comparative toxicity of non-steroidal anti-inflammatory agentsG Singh, D R Ramey, D Morfeld, et al.
JAMA|June 13, 1977
Clinical history as a screening test for ankylosing spondylitisA Calin, J Porta, J F Fries, et al.
Arthritis and Rheumatism|February 1, 1980
Measurement of patient outcome in arthritisJ F Fries, P Spitz, R G Kraines, et al.
The Journal of Rheumatology|October 1, 1993
Fractures in rheumatoid arthritis: an evaluation of associated risk factorsB A Michel, D A Bloch, F Wolfe, et al.
The Journal of Rheumatology|September 1, 1989
Predisposing factors in polymyositis-dermatomyositis: results of a nationwide surveyM G Lyon, D A Bloch, B Hollak, et al.
Arthritis and Rheumatism|December 1, 1994
Measurement of health status in children with juvenile rheumatoid arthritisG Singh, B H Athreya, J F Fries, et al.
The Journal of Rheumatology|May 1, 1997
Response to therapy in rheumatoid arthritis is influenced by immediately prior therapyJ F Fries, C A Williams, G Singh, et al.
Arthritis and Rheumatism|March 1, 1993
The relative toxicity of disease-modifying antirheumatic drugsJ F Fries, C A Williams, D Ramey, et al.
Pageof 25

Showing results (161-170 of 247) with videos related to

Sort By:
Pageof 25
Arthritis and Rheumatism|November 1, 1990
Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisJ F Fries, G Singh, L Lenert, et al.
The Journal of Rheumatology|July 1, 1989
The natural history of ankylosing spondylitis: is the disease really changing?J F Fries, G Singh, D A Bloch, et al.
Pharmacology & Therapeutics|April 1, 1994
Comparative toxicity of non-steroidal anti-inflammatory agentsG Singh, D R Ramey, D Morfeld, et al.
JAMA|June 13, 1977
Clinical history as a screening test for ankylosing spondylitisA Calin, J Porta, J F Fries, et al.
Arthritis and Rheumatism|February 1, 1980
Measurement of patient outcome in arthritisJ F Fries, P Spitz, R G Kraines, et al.
The Journal of Rheumatology|October 1, 1993
Fractures in rheumatoid arthritis: an evaluation of associated risk factorsB A Michel, D A Bloch, F Wolfe, et al.
The Journal of Rheumatology|September 1, 1989
Predisposing factors in polymyositis-dermatomyositis: results of a nationwide surveyM G Lyon, D A Bloch, B Hollak, et al.
Arthritis and Rheumatism|December 1, 1994
Measurement of health status in children with juvenile rheumatoid arthritisG Singh, B H Athreya, J F Fries, et al.
The Journal of Rheumatology|May 1, 1997
Response to therapy in rheumatoid arthritis is influenced by immediately prior therapyJ F Fries, C A Williams, G Singh, et al.
Arthritis and Rheumatism|March 1, 1993
The relative toxicity of disease-modifying antirheumatic drugsJ F Fries, C A Williams, D Ramey, et al.
Pageof 25